Cross-Sector entity

World Health Organization

Company
6.7

Bundibugyo virus is the most frequent co-covered peer, appearing in 6 of the 19 tracked stories. Across a 19-day span, the pace is roughly 7 stories per week. The busiest single day carried 4. The clearest coverage concentration is regulation: 8 of 19 stories, with the rest divided among 7 other categories.

19 verified stories tracked

Last mentioned: Aug 7, 2026

Entity pulse

Recent coverage · World Health Organization

19 stories
6.7 avg impact
16% positive
58% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 42 percentage points.

  • 16% positive
  • 26% neutral
  • 58% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about World Health Organization

Bundibugyo virus is the most frequent co-covered peer, appearing in 6 of the 19 tracked stories. Across a 19-day span, the pace is roughly 7 stories per week. The busiest single day carried 4. The clearest coverage concentration is regulation: 8 of 19 stories, with the rest divided among 7 other categories. This profile follows 19 Cross-Sector stories mentioning World Health Organization across the period from July 20, 2026 to August 7, 2026. Each carries 2.2 original sources on average. Negative sentiment appears in 58% of the tracked stories.

Stories tracked
19
Per week
7
Negative
58%
Sources per story
2.2

Computed from the 19 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering World Health Organization. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. High-level international visits

    WHO Director-General Tedros Adhanom Ghebreyesus arrives in Kinshasa; Africa CDC head Jean Kaseya visits Bunia, warning that 80% of cases are from community spread.

  2. Healthcare workers' ultimatum

    Healthcare workers in Mongbwalu issue a 24-hour ultimatum over unpaid wages, threatening escalation.

  3. 3,000 Cases Milestone

    Total cases reach 3,075, with 1,354 deaths, amid healthcare strikes and calls for accelerated countermeasure development.

  4. Elikya Treatment Center strike

    About 100 health workers at the Elikya Ebola Treatment Center in Bunia strike over unpaid bonuses, paralyzing patient care.

  5. Government releases updated data

    Congo's Ministry of Health confirms 2,973 cases and 1,309 deaths, the fastest-growing outbreak on record.

  6. First Experimental Vaccine Volunteer Dosed

    Oxford University reports that the first volunteer group has received its candidate vaccine specifically targeting Bundibugyo.

  7. Strike at Bunia General Hospital

    Health workers at the region's largest hospital strike over unpaid salaries, stating they have not been paid since the outbreak started.

  8. 2,000 Cases Surpassed

    Cumulative confirmed cases exceed 2,000, with rapid spread noted in conflict zones.

  9. First-in-Human Trial Begins

    A Phase 1 clinical trial of the ChAdOx1-biEBOV vaccine, enrolling 50 healthy adults, commences with 4,000 doses supplied by the Serum Institute of India.

  10. WHO sounds alarm

    WHO reports that 80% of new cases are from unknown chains of transmission; striking workers agree to return if paid within 72 hours.

  11. Health worker strike

    Dozens of healthcare workers at an Ebola treatment centre in Bunia go on strike over unpaid salaries and bonuses.

  12. Staff strike at Rwampara General Hospital

    Dozens of workers at the epicenter treatment center strike over two months of unpaid salaries, shutting the facility and blocking roads.

  13. Record outbreak data confirmed

    Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.

  14. Virus spreads to two more provinces

    Health Minister Kamba announces the outbreak has reached two additional provinces beyond Ituri, further complicating containment.

  15. Clinical trials for treatments launched

    Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.

  16. Kenya court suspends U.S.-backed facility

    A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.

  17. Experimental treatment study begins

    A clinical study of two candidate Ebola treatments launches at a different treatment center in Ituri province, not the one that would later strike.

  18. Uganda declared Ebola-free

    Uganda discharges its last Ebola patient and declares the country free of the disease.

  19. WHO Declares Public Health Emergency

    The World Health Organization declares the Bundibugyo Ebola outbreak in the DRC and Uganda a Public Health Emergency of International Concern (PHEIC), accelerating vaccine development and funding.

  20. Ebola outbreak officially declared

    Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.

Stories mentioning World Health Organization 19

Healthcare funding Negative 6

WHO Chief: 3,874 Ebola Cases & Doubling Hotspots Demand $500M+ Response

The WHO director-general warns that Ebola cases in DRC are doubling weekly in hotspots, reaching 3,874 confirmed cases and 1,751 deaths. The US has committed over $500 million to the response, but health system and security gaps remain critical. Urgent investments in surveillance, health worker support, and community access are needed.

2 sources

Source: freemalaysiatoday.com · bangkokpost.com

Healthcare health it Strongly negative 8

Ebola Outbreak: 80% Community Spread Exposes Contact Tracing Collapse in DRC

The Bundibugyo Ebola outbreak in DRC has killed 1,700 people as community transmission drives 80% of new cases, revealing critical gaps in digital contact tracing and surveillance. With no approved vaccines, health IT innovators face an urgent call to deploy mobile tracing, AI analytics, and rapid diagnostics. Ongoing clinical trials may offer hope, but the immediate need is for tech-enabled outbreak management.

2 sources

Source: MedPage Today · greatlakesadvocate.com.au

Biotech clinical trial Neutral 5

Ebola Treatment Trial at Risk as Strike Stalls Outbreak Epicenter

Biotech's race to develop therapies for the Bundibugyo Ebola strain faces a new hurdle as a strike at Congo's outbreak epicenter disrupts critical clinical operations. The study of two candidate treatments, launched in early July, could be jeopardized by collapsed workforce morale at nearby facilities.

Source: mcall.com

Healthcare market trends Negative 6

Hepatitis C Missed Elimination Targets Could Cost Australia $1.4B

A new report from Hepatitis Australia highlights the staggering financial and human toll of failing to eliminate hepatitis B and C by 2030. With $1.4 billion in avoidable costs for hepatitis C alone, including workforce and healthcare burdens, the call to action emphasizes the need for enhanced screening, public awareness, and accessible treatment pathways.

5 sources

Source: mudgeeguardian.com.au · southcoastregister.com.au

Biotech clinical trial Strongly negative 7

Ebola Outbreak Tops 3,000 Cases, Oxford Starts Clinical Trial for Bundibugyo Vaccine

DRC’s 17th Ebola outbreak has exploded to 3,075 cases and 1,354 deaths, with 1,000 new infections in just 10 days. The Bundibugyo strain has no approved vaccine or treatment, igniting a biotech race: Oxford University has dosed its first volunteer with an experimental vaccine, while other candidates are fast-tracked, creating high-stakes opportunities for pharma developers.

2 sources

Source: english.aawsat.com · manilatimes.net

Biotech pharma Strongly negative 8

Bundibugyo Ebola Hits 2,973 Cases, 1,309 Deaths: A Biotech Call to Arms

The Bundibugyo virus outbreak is the fastest-growing on record, with a 44% case fatality rate and no approved vaccine or therapy. Biopharma companies and researchers face a critical test as containment fails and the need for medical countermeasures becomes more urgent.

2 sources
Healthcare regulation Negative 6

U.S. Measles Cases Hit 2,318 in 2026, Surpassing 2025 Record and Jeopardizing Elimination Status

The CDC reports 2,318 measles cases in the U.S. as of July 2026, already exceeding the 2025 total of 2,289. With kindergarten vaccination rates at 92.5% and a major outbreak in Utah undercounted by up to 4x, the nation faces a WHO review this November that could strip its measles-free status, with profound regulatory and healthcare cost consequences.

2 sources

Source: MedPage Today · STAT News